BIAcore for macromolecular interaction.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 9503595)

Published in Curr Opin Biotechnol on February 01, 1998

Authors

M Fivash1, E M Towler, R J Fisher

Author Affiliations

1: Data Management Services, Inc., Frederick, MD, USA.

Articles citing this

Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. Biophys J (1998) 2.49

Dual interactions of the translational repressor Paip2 with poly(A) binding protein. Mol Cell Biol (2001) 2.07

Folding-based electrochemical biosensors: the case for responsive nucleic acid architectures. Acc Chem Res (2010) 1.75

An Arabidopsis dual-localized pentatricopeptide repeat protein interacts with nuclear proteins involved in gene expression regulation. Plant Cell (2011) 1.16

Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene (2011) 1.14

Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter. Nucleic Acids Res (2005) 1.07

Binding kinetics and activity of human poly(ADP-ribose) polymerase-1 on oligo-deoxyribonucleotide substrates. J Mol Recognit (2009) 0.83

Comparison of surface plasmon resonance, resonant waveguide grating biosensing and enzyme linked immunosorbent assay (ELISA) in the evaluation of a dengue virus immunoassay. Biosensors (Basel) (2013) 0.82

Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3). PLoS One (2013) 0.81

Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens. Front Immunol (2015) 0.80

On-chip Escherichia coli culture, purification, and detection of expressed proteins. Eur Biophys J (2006) 0.77

A small inhibitor of the interaction between Bax and Bcl-X(L) can synergize with methylprednisolone to induce apoptosis in Bcl-X(L)-overexpressing breast-cancer cells. J Cancer Res Clin Oncol (2003) 0.76

A radioisotope label-free alpha-bungarotoxin-binding assay using BIAcore sensor chip technology for real-time analysis. Anal Biochem (2009) 0.75

Quantitative assessment of complex formation of nuclear-receptor accessory proteins. Biochem J (2000) 0.75

Microfluidic Channels on Nanopatterned Substrates: Monitoring Protein Binding to Lipid Bilayers with Surface-Enhanced Raman Spectroscopy. Chem Phys Lett (2010) 0.75

Quantifying intracellular protein binding thermodynamics during mechanotransduction based on FRET spectroscopy. Methods (2013) 0.75

SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs. Biosensors (Basel) (2015) 0.75

Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics. J Control Release (2015) 0.75

Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies. Sci Rep (2017) 0.75

Investigating cyclic nucleotide and cyclic dinucleotide binding to HCN channels by surface plasmon resonance. PLoS One (2017) 0.75

Articles by these authors

Predictors of laparoscopic complications after formal training in laparoscopic surgery. JAMA (1993) 2.37

Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci U S A (1987) 2.20

Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07

Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc Natl Acad Sci U S A (1990) 1.96

The ets gene family. Cell Growth Differ (1992) 1.67

Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene (1990) 1.65

Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65

Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58

ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J (1995) 1.56

Correction of the NMR structure of the ETS1/DNA complex. J Biomol NMR (1997) 1.50

Mutants of Azotobacter vinelandii unable to fix nitrogen. Biochim Biophys Acta (1969) 1.44

Characterization and localization of the products of the human homologs of the v-ets oncogene. Oncogene (1988) 1.31

Universal immuno-PCR for ultra-sensitive target protein detection. Nucleic Acids Res (1993) 1.27

A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C. Mol Cell Biol (1988) 1.23

Energy-linked nicotinamide adenine dinucleotide transhydrogenase in membrane particles from Escherchia coli. Biochim Biophys Acta (1971) 1.22

Age-related response to lidocaine-prilocaine (EMLA) emulsion and effect of music distraction on the pain of intravenous cannulation. Pediatrics (1994) 1.19

The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell (1995) 1.16

Measurement of exocytosis by amperometry in adrenal chromaffin cells: effects of clostridial neurotoxins and activation of protein kinase C on fusion pore kinetics. Biochimie (2000) 1.14

Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials (2004) 1.13

Coupling of oscillatory activity between muscles is strikingly reduced in a deafferented subject compared with normal controls. J Neurophysiol (2004) 1.13

Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol Cell Biol (2001) 1.12

Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res (1994) 1.11

Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex. Mol Cell Biol (1990) 1.11

Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07

Chemical cleavage at aspartyl residues for protein identification. Anal Chem (2001) 1.06

Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family. Oncogene (1993) 1.04

Split-course accelerated therapy in head and neck cancer: an analysis of toxicity. Int J Radiat Oncol Biol Phys (1995) 0.98

Laparoscopic surgical training: effectiveness and impact on urological surgical practice patterns. J Urol (1993) 0.97

An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem (1994) 0.96

Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer (2008) 0.96

Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry (1996) 0.96

Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis. Oncogene (1994) 0.92

Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer (2000) 0.92

Refolding proteins by gel filtration chromatography. FEBS Lett (1994) 0.92

Ewing's sarcoma: long-term follow-up in 49 patients treated from 1967 to 1989. Int J Radiat Oncol Biol Phys (1993) 0.91

Energy-linked and energy-independent transhydrogenase activities in Escherichia coli vesicles. Biochim Biophys Acta (1975) 0.90

Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease. Biochemistry (1998) 0.90

ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl (1990) 0.89

c-Ets-1 protein is hyperphosphorylated during mitosis. Oncogene (1993) 0.89

The ets family of genes: molecular biology and functional implications. Curr Top Microbiol Immunol (1989) 0.89

Monoclonal antibodies specific to human ETS-2 oncoprotein: recognition of epitopes clustered on the B domain. Hybridoma (1990) 0.88

ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol (1995) 0.87

Control of membrane fusion dynamics during regulated exocytosis. Biochem Soc Trans (2001) 0.87

Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression. Oncol Res (1998) 0.87

The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases. J Mol Biol (1997) 0.85

Protein markers in colorectal cancer: predictors of liver metastasis. Ann Surg (1999) 0.85

Analysis of human immunodeficiency virus type 1 containing HERV-K protease. AIDS Res Hum Retroviruses (2000) 0.84

An autoradiographic study of the early effects of 7,12-dimethylbenz(a)anthracene and progesterone on DNA synthesis in rat mammary epithelial cells and subsequent tumour development. Br J Cancer (1972) 0.84

Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res (1998) 0.84

Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays. J Biol Chem (2001) 0.84

Properties of a soluble nitrogenase in Azotobacter. J Bacteriol (1970) 0.84

Properties and interpretation of the Woolf and Scatchard plots in analysing data from steroid receptor assays. J Steroid Biochem (1983) 0.84

Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) (2003) 0.83

A field trial of ketamine anaesthesia in the horse. Equine Vet J (1984) 0.83

Escherichia coli nicotinamide adenine nucleotide transhydrogenase driven by aerobic oxidation and its enhancement by an energy transfer factor from rat-liver mitochondria. Biochem Biophys Res Commun (1970) 0.83

Urological laparoscopic practice patterns 1 year after formal training. J Urol (1994) 0.82

Selective disaggregation of the H+-translocating ATPase. Isolation of two discrete complexes of the rutamycin-insensitive ATPase differing in mitochondrial membrane-binding properties. J Biol Chem (1981) 0.82

Regulation of kiss-and-run exocytosis. Trends Cell Biol (2001) 0.82

Inhibition of the membrane-bound adenosine triphosphatase of Escherichia coli by dicyclohexylcarbodi-imide. Biochem J (1977) 0.81

Evidence for a nucleotide-dependent topoisomerase activity from yeast mitochondria. Curr Genet (1994) 0.80

Relationship between radiation response and p53 status in human bladder cancer cells. Int J Radiat Biol (1997) 0.80

The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells. Biochim Biophys Acta (1996) 0.80

Control of NAD(P)+-transhydrogenase levels in Escherichia coli. Arch Biochem Biophys (1976) 0.79

Pyruvate-supported nitrogen fixation by cell-free extracts of Bacillus polymyxa. Biochem J (1970) 0.79

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia. Cancer (1992) 0.79

Testicular doses in definitive radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (1995) 0.79

Heterogeneity of in vitro radiosensitivity in human bladder cancer cells. Radiat Oncol Investig (1999) 0.79

A soluble mitochondrial ATP synthetase complex catalyzing ATP-phosphate and ATP-ADP exchange. Proc Natl Acad Sci U S A (1971) 0.78

A multi-centre, double-blind trial in general practice comparing the hypnotic efficacy and event profiles of flunitrazepam and temazepam. Pharmatherapeutica (1985) 0.78

Dependence of Escherichia coli pyridine nucleotide transhydrogenase on phospholipids and its sensitivity. Biochem Biophys Res Commun (1976) 0.77

Oncogenes and the mitogenic signal pathway. Important Adv Oncol (1989) 0.77

HIV-1 RT enhances the activity of a tethered dimer of HIV-1 proteinase. Biochem Biophys Res Commun (1996) 0.77

Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg (1998) 0.77

The ets genes in cells and viruses: implications for leukemias and other human diseases. Ann N Y Acad Sci (1987) 0.77

Effect of early inhibition of DNA synthesis by hydroxyurea on 7,12-dimethylbenz(a)anthracene mammary carcinogenesis in the rat. J Pathol (1974) 0.77

The ETS family of genes: structural analysis, gene products, and involvement in neoplasia and other pathologies. Prog Clin Biol Res (1990) 0.76

Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group. Int J Radiat Oncol Biol Phys (1995) 0.76

High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma. Cancer Treat Rep (1984) 0.76

Inactivation of firefly luciferase and rat erythrocyte ATPase by ultrasound. Membr Biochem (1994) 0.76

T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (1995) 0.75

RE: J Kiffer et al. - Letter to the Editor regarding F Schwarz et al. - Are single fractions of radiotherapy suitable for plantar fasciitis? Australas Radiol (2005) 0.75

Personality correlates of dogmatism: methodological problems. J Consult Clin Psychol (1970) 0.75

Perceptions of social desirability and frequency of occurrence of traits and the probability that the traits will be endorsed. Percept Mot Skills (1970) 0.75

Adequacy of amino acids in diets fed to lactating dairy cows. J Dairy Sci (1997) 0.75

Subunit interaction in the mitochondrial H+-translocating ATPase. Association of the 26,500-dalton atpase binding protein and oligomycin sensitivity conferral protein with F1-ATPase. J Biol Chem (1983) 0.75

Expression and characterization of a protein encoded by the human c-myc exon 1 in Escherichia coli. Gene Anal Tech (1989) 0.75

Effect of dibromothymoquinone on succinate-linked reactions in Escherichia coli. FEBS Lett (1976) 0.75

Lactational performance of cows fed low or high ruminally undegradable protein prepartum and supplemental methionine and lysine postpartum. J Dairy Sci (1997) 0.75

Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience. Radiother Oncol (1996) 0.75

A third-party consultation workshop on the India-Pakistan conflict. J Soc Psychol (1980) 0.75

Viral myc genes and their cellular homologs. Gene Amplif Anal (1986) 0.75

THE RELATIONSHIP BETWEEN PERSONAL DESIRABILITY AND ENDORSEMENT WITH A FORCED-CHOICE TECHNIQUE. Multivariate Behav Res (1971) 0.75

Oncogenes: molecular probes for clinical application in malignant diseases. Gene Amplif Anal (1986) 0.75

Immunologic detection of protein antigens after phenol-chloroform denaturation. Gene Anal Tech (1989) 0.75

Characterization of rat liver mitochondria depleted of inner membrane components by chloramphenicol treatment of regenerating rat liver. Arch Biochem Biophys (1976) 0.75

The effect of oligomycin and factor C on respiration linked transhydrogenase in depleted submitochondrial particles. Biochem Biophys Res Commun (1971) 0.75

Subunit interaction in the mitochondrial H+-translocating ATPase. The role of oligomycin sensitivity conferral protein and coupling factor 6 in ATPase binding and Pi-ATP exchange in mitochondrial membranes. J Biol Chem (1983) 0.75